ExploringDark Kinase Biology
Unlocking molecular vulnerabilities in cancer through precision targeting
Data-Driven Discovery
Integrating expression profiles, mutation data, and functional dependencies to identify actionable molecular vulnerabilities in cancer subtypes
Precision Therapeutics
Developing selective kinase inhibitors targeting subtype-specific vulnerabilities, enabling targeted therapies with improved efficacy and reduced toxicity
Molecular Vulnerability Mapping
Identifying context-dependent vulnerabilities where cancer cells become dependent on specific molecular pathways, creating opportunities for selective therapeutic intervention